In lung cancer, a report showed that high PRDX4 expression levels were significantly correlated with higher rates of recurrence and shorter disease-free survival (DFS) in patients with lung squamous cell carcinoma, but not in patients with lung adenocarcinoma 22. This evidence concerns the gene PRDX4 and lung cancer.